Guided Therapeutics Inc GTHP
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if GTHP is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $0.11
- Day Range
- $0.10–0.10
- 52-Week Range
- $0.06–0.30
- Bid/Ask
- $0.07 / $0.11
- Market Cap
- $5.56 Mil
- Volume/Avg
- 4,052 / 34,395
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 52.16
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Guided Therapeutics Inc is a medical technology company. It is engaged in developing medical devices that have the potential to improve healthcare. Its primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device and extension of its cancer detection technology into other cancers, including esophageal. The company generates revenue from the sale of medical devices.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 4
- Website
- https://www.guidedinc.com
Valuation
|
Metric
|
GTHP
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 52.16 |
Price/Cash Flow | — |
Price/Earnings
GTHP
Financial Strength
|
Metric
|
GTHP
|
|---|---|
Quick Ratio | 0.12 |
Current Ratio | 0.29 |
Interest Coverage | −11.57 |
Quick Ratio
GTHP
Profitability
|
Metric
|
GTHP
|
|---|---|
Return on Assets (Normalized) | −77.44% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
GTHP
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Kmrcmyxg | Fbxdm | $185.5 Bil | |
SYK
| Stryker Corp | Hmtzcnzpjv | Jjd | $128.2 Bil | |
MDT
| Medtronic PLC | Dfclzvpmv | Qcnrc | $106.7 Bil | |
BSX
| Boston Scientific Corp | Mjpssqrd | Khcpsjf | $99.0 Bil | |
DXCM
| DexCom Inc | Mhgzssztr | Ksxb | $53.1 Bil | |
EW
| Edwards Lifesciences Corp | Qkvdxbbc | Jqcybx | $52.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Nvyqnhtv | Xmtsq | $24.9 Bil | |
ALGN
| Align Technology Inc | Cnkdfgcf | Fdbpl | $23.5 Bil | |
PHG
| Koninklijke Philips NV ADR | Knrtnkz | Hdlhlr | $18.9 Bil | |
PODD
| Insulet Corp | Rxnrtxrsp | Xnnynp | $11.7 Bil |